Payment overview · 2025
General Payments
$165.62
7 reported records · 4 companies
Healthcare provider profile · identity verified
Rajeev Gupta, MD
Allopathic & Osteopathic Physicians|Family Medicine|Geriatric Medicine · MORRISTOWN, TN · NPI 1225089725
Verified facts
What the public records show
CMS Open Payments records show Rajeev Gupta, MD received $165.62 in general payments during 2025 across 7 reported records.
Inspire Medical Systems, Inc. accounted for 37.4% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 5 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Ozempic.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Ozempic as an associated drug or biological on 261625 records involving 77793 distinct recipient NPIs. Public Medicare Part D data also shows 33 claims for Ozempic by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Inspire Medical Systems, Inc. | Unresolved — no canonical attribution shown | $62.01 | 37.4% | 2 | 2025 |
| Novo Nordisk Inc | Unresolved — no canonical attribution shown | $45.99 | 27.8% | 2 | 2025 |
| Neurocrine BioSciences, Inc. | Unresolved — no canonical attribution shown | $40.48 | 24.4% | 2 | 2025 |
| INOGEN, INC. | Unresolved — no canonical attribution shown | $17.14 | 10.3% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $165.62 | 7 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| INSPIRE Normalized: inspire |
Device | Inspire Medical Systems, Inc. | $62.01 | 2 | 2025 |
Source payment records
|
|||||
| INGREZZA Normalized: ingrezza |
Drug | Neurocrine BioSciences, Inc. | $40.48 | 2 | 2025 |
Source payment records
|
|||||
| Ozempic Normalized: ozempic |
Drug | Novo Nordisk Inc | $30.77 | 1 | 2025 |
Source payment records
|
|||||
| Rybelsus Normalized: rybelsus |
Drug | Novo Nordisk Inc | $30.77 | 1 | 2025 |
Source payment records
|
|||||
| INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH Normalized: inogen one g5 oxygen concentrator bluetooth |
Device | INOGEN, INC. | $17.14 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| Ozempic ozempic |
2025 | Ozempic | 2024 | 33 Beneficiary count suppressed |
exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Ozempic open payments reported associated product |
CMS Open Payments — General Payments 261625 supporting records · 77793 recipient NPIs · example record 1188130076 |
Ozempic · 2024 Exact normalized brand match · 1 Part D row |
33 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Levothyroxine Sodium | Levothyroxine Sodium | 1544 | 373 |
| Atorvastatin Calcium | Atorvastatin Calcium | 1248 | 301 |
| Pantoprazole Sodium | Pantoprazole Sodium | 914 | 232 |
| Sertraline Hcl | Sertraline Hcl | 758 | 171 |
| Amlodipine Besylate | Amlodipine Besylate | 749 | 214 |
| Furosemide | Furosemide | 528 | 132 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 504 | 142 |
| Metoprolol Tartrate | Metoprolol Tartrate | 494 | 123 |
| Donepezil Hcl | Donepezil Hcl | 465 | 101 |
| Omeprazole | Omeprazole | 461 | 128 |
| Trazodone Hcl | Trazodone Hcl | 458 | 120 |
| Eliquis | Apixaban | 454 | 93 |
| Mirtazapine | Mirtazapine | 431 | 106 |
| Tamsulosin Hcl | Tamsulosin Hcl | 426 | 91 |
| Lisinopril | Lisinopril | 424 | 123 |
| Losartan Potassium | Losartan Potassium | 397 | 105 |
| Potassium Chloride | Potassium Chloride | 386 | 102 |
| Clopidogrel | Clopidogrel Bisulfate | 332 | 86 |
| Metformin Hcl | Metformin Hcl | 330 | 86 |
| Memantine Hcl | Memantine Hcl | 327 | 71 |
| Montelukast Sodium | Montelukast Sodium | 325 | 96 |
| Metoprolol Succinate | Metoprolol Succinate | 321 | 83 |
| Simvastatin | Simvastatin | 315 | 81 |
| Hydrochlorothiazide | Hydrochlorothiazide | 308 | 80 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 247 | 61 |
| Pravastatin Sodium | Pravastatin Sodium | 227 | 58 |
| Hydralazine Hcl | Hydralazine Hcl | 222 | 51 |
| Divalproex Sodium | Divalproex Sodium | 216 | 51 |
| Carvedilol | Carvedilol | 205 | 48 |
| Glipizide Er | Glipizide | 197 | 57 |
| Quetiapine Fumarate | Quetiapine Fumarate | 196 | 44 |
| Fluticasone Propionate | Fluticasone Propionate | 192 | 67 |
| Allopurinol | Allopurinol | 190 | 50 |
| Famotidine | Famotidine | 171 | 46 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 170 | 130 |
| Atenolol | Atenolol | 167 | 38 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 151 | 35 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 150 | 33 |
| Escitalopram Oxalate | Escitalopram Oxalate | 149 | 43 |
| Bumetanide | Bumetanide | 146 | 30 |
| Duloxetine Hcl | Duloxetine Hcl | 146 | 41 |
| Prednisone | Prednisone | 145 | 52 |
| Xarelto | Rivaroxaban | 145 | 24 |
| Metformin Hcl Er | Metformin Hcl | 142 | 40 |
| Finasteride | Finasteride | 141 | 35 |
| Lovastatin | Lovastatin | 136 | 36 |
| Clonidine Hcl | Clonidine Hcl | 135 | 49 |
| Fluoxetine Hcl | Fluoxetine Hcl | 128 | 30 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 126 | 47 |
| Amiodarone Hcl | Amiodarone Hcl | 121 | 34 |
| Spironolactone | Spironolactone | 108 | 31 |
| Benazepril Hcl | Benazepril Hcl | 105 | 22 |
| Alendronate Sodium | Alendronate Sodium | 102 | 21 |
| Shingrix | Varicella-Zoster Ge/As01b/Pf | 102 | 81 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 100 | 20 |
| Cefdinir | Cefdinir | 99 | 79 |
| Ropinirole Hcl | Ropinirole Hcl | 94 | 25 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 93 | 74 |
| Azithromycin | Azithromycin | 92 | 83 |
| Ezetimibe | Ezetimibe | 92 | 26 |
| Midodrine Hcl | Midodrine Hcl | 92 | 33 |
| Buspirone Hcl | Buspirone Hcl | 87 | 30 |
| Cephalexin | Cephalexin | 84 | 55 |
| Citalopram Hbr | Citalopram Hydrobromide | 84 | 22 |
| Celecoxib | Celecoxib | 81 | 29 |
| Glimepiride | Glimepiride | 81 | 25 |
| Synthroid | Levothyroxine Sodium | 81 | 21 |
| Levetiracetam | Levetiracetam | 79 | 11 |
| Bethanechol Chloride | Bethanechol Chloride | 78 | 18 |
| Olanzapine | Olanzapine | 78 | 16 |
| Glipizide | Glipizide | 77 | 23 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 76 | 12 |
| Fluconazole | Fluconazole | 75 | 50 |
| Fenofibrate | Fenofibrate | 74 | 24 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 72 | 18 |
| Symbicort | Budesonide/Formoterol Fumarate | 71 | 13 |
| Aripiprazole | Aripiprazole | 66 | 16 |
| Warfarin Sodium | Warfarin Sodium | 64 | 12 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 62 | 17 |
| Digoxin | Digoxin | 59 | 17 |
| Meloxicam | Meloxicam | 59 | 20 |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 58 | 15 |
| Nifedipine Er | Nifedipine | 58 | 18 |
| Pioglitazone Hcl | Pioglitazone Hcl | 58 | 18 |
| Farxiga | Dapagliflozin Propanediol | 56 | 17 |
| Jardiance | Empagliflozin | 54 | 16 |
| Gabapentin | Gabapentin | 52 | 17 |
| Primidone | Primidone | 52 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 51 | 19 |
| Cyanocobalamin Injection | Cyanocobalamin (Vitamin B-12) | 49 | 11 |
| Diclofenac Sodium | Diclofenac Sodium | 49 | 16 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 48 | suppressed |
| Bupropion Xl | Bupropion Hcl | 48 | 14 |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 48 | suppressed |
| Linzess | Linaclotide | 47 | suppressed |
| Novolog Flexpen | Insulin Aspart | 45 | suppressed |
| Nystatin | Nystatin | 45 | 31 |
| Methimazole | Methimazole | 44 | 11 |
| Myrbetriq | Mirabegron | 44 | suppressed |
| Sucralfate | Sucralfate | 43 | suppressed |
| Risperidone | Risperidone | 41 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 41 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 39 | 17 |
| Mounjaro | Tirzepatide | 39 | suppressed |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 39 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 38 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 38 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 37 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 36 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 36 | suppressed |
| Estradiol | Estradiol | 35 | 13 |
| Tresiba Flextouch U-100 | Insulin Degludec | 35 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 35 | 17 |
| Doxycycline Hyclate | Doxycycline Hyclate | 34 | 28 |
| Lamotrigine | Lamotrigine | 34 | suppressed |
| Lactulose | Lactulose | 33 | 12 |
| Latanoprost | Latanoprost | 33 | 12 |
| Ozempic | Semaglutide | 33 | suppressed |
| Chlorthalidone | Chlorthalidone | 32 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 32 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 32 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 30 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 30 | suppressed |
| Nitroglycerin Patch | Nitroglycerin | 30 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 30 | 22 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 29 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 28 | 15 |
| Oxybutynin Chloride | Oxybutynin Chloride | 27 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 27 | 20 |
| Valsartan | Valsartan | 27 | suppressed |
| Entresto | Sacubitril/Valsartan | 26 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 26 | suppressed |
| Amoxicillin | Amoxicillin | 25 | 23 |
| Irbesartan | Irbesartan | 25 | suppressed |
| Rivastigmine | Rivastigmine | 25 | suppressed |
| Acyclovir | Acyclovir | 24 | 11 |
| Enalapril Maleate | Enalapril Maleate | 24 | suppressed |
| Lidocaine Hcl | Lidocaine Hcl | 24 | 17 |
| Breo Ellipta | Fluticasone/Vilanterol | 23 | suppressed |
| Calcitriol | Calcitriol | 23 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 22 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 21 | suppressed |
| Gemtesa | Vibegron | 21 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 21 | suppressed |
| Methylprednisolone | Methylprednisolone | 21 | 21 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 21 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 20 | suppressed |
| Methocarbamol | Methocarbamol | 20 | 12 |
| Ondansetron Odt | Ondansetron | 20 | 17 |
| Tresiba Flextouch U-200 | Insulin Degludec | 20 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 20 | 13 |
| Bupropion Hcl Sr | Bupropion Hcl | 19 | suppressed |
| Spironolactone-Hctz | Spironolact/Hydrochlorothiazid | 19 | suppressed |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 18 | suppressed |
| Dexamethasone | Dexamethasone | 18 | 17 |
| Gemfibrozil | Gemfibrozil | 18 | suppressed |
| Lansoprazole | Lansoprazole | 18 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 18 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 18 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 18 | suppressed |
| Silodosin | Silodosin | 18 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 17 | suppressed |
| Benazepril-Hydrochlorothiazide | Benazepril/Hydrochlorothiazide | 17 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 17 | suppressed |
| Bydureon Bcise | Exenatide Microspheres | 17 | suppressed |
| Carbamazepine | Carbamazepine | 17 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 17 | suppressed |
| Januvia | Sitagliptin Phosphate | 17 | suppressed |
| Letrozole | Letrozole | 17 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 17 | suppressed |
| Nitroglycerin | Nitroglycerin | 17 | 13 |
| Sotalol | Sotalol Hcl | 17 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 16 | 15 |
| Linezolid | Linezolid | 16 | 12 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 16 | suppressed |
| Clotrimazole | Clotrimazole | 15 | suppressed |
| Metolazone | Metolazone | 15 | suppressed |
| Dexlansoprazole Dr | Dexlansoprazole | 14 | suppressed |
| Lidocaine | Lidocaine | 14 | suppressed |
| Permethrin | Permethrin | 14 | suppressed |
| Rivastigmine | Rivastigmine Tartrate | 14 | suppressed |
| Sodium Polystyrene Sulfonate | Sodium Polystyrene Sulfonate | 14 | 12 |
| Amitriptyline Hcl | Amitriptyline Hcl | 13 | suppressed |
| Amlodipine-Valsartan | Amlodipine Besylate/Valsartan | 13 | suppressed |
| Arnuity Ellipta | Fluticasone Furoate | 13 | suppressed |
| Ibuprofen | Ibuprofen | 13 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 13 | suppressed |
| Ampicillin Trihydrate | Ampicillin Trihydrate | 12 | 11 |
| Bupropion Hcl | Bupropion Hcl | 12 | suppressed |
| Clindamycin Hcl | Clindamycin Hcl | 12 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 12 | suppressed |
| Janumet | Sitagliptin Phos/Metformin Hcl | 12 | suppressed |
| Klor-Con M10 | Potassium Chloride | 12 | suppressed |
| Levemir Flexpen | Insulin Detemir | 12 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 12 | suppressed |
| Methotrexate | Methotrexate Sodium | 12 | suppressed |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 12 | suppressed |
| Sulfasalazine | Sulfasalazine | 12 | suppressed |
| Alcohol Prep Pads | Alcohol Antiseptic Pads | 11 | suppressed |
| Aspirin-Dipyridamole Er | Aspirin/Dipyridamole | 11 | suppressed |
| Ceftriaxone | Ceftriaxone Sodium | 11 | 11 |
| Comfort Ez Pen Needle | Pen Needle, Diabetic | 11 | suppressed |
| Creon | Lipase/Protease/Amylase | 11 | suppressed |
| Easy Touch Alcohol Prep Pads | Alcohol Antiseptic Pads | 11 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 11 | suppressed |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 11 | suppressed |
| Isosorbide Mononitrate | Isosorbide Mononitrate | 11 | suppressed |
| Levofloxacin | Levofloxacin | 11 | suppressed |
| Nyamyc | Nystatin | 11 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 11 | suppressed |
| Ramipril | Ramipril | 11 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $165.62 · 7 records | Inspire Medical Systems, Inc. | INGREZZA, INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH, INSPIRE, Ozempic, Rybelsus | 1 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Ozempic play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with Novo Nordisk Inc?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error